A

Adicon Holdings Ltd
HKEX:9860

Watchlist Manager
Adicon Holdings Ltd
HKEX:9860
Watchlist
Price: 6.24 HKD -2.65% Market Closed
Market Cap: 4.5B HKD
Have any thoughts about
Adicon Holdings Ltd?
Write Note

Adicon Holdings Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Adicon Holdings Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
A
Adicon Holdings Ltd
HKEX:9860
Cash & Cash Equivalents
ÂĄ1.7B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Cash & Cash Equivalents
ÂĄ1.8B
CAGR 3-Years
-2%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Cash & Cash Equivalents
ÂĄ622.8m
CAGR 3-Years
-16%
CAGR 5-Years
9%
CAGR 10-Years
9%
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Cash & Cash Equivalents
ÂĄ4.6B
CAGR 3-Years
-10%
CAGR 5-Years
-1%
CAGR 10-Years
17%
Dian Diagnostics Group Co Ltd
SZSE:300244
Cash & Cash Equivalents
ÂĄ1.8B
CAGR 3-Years
-6%
CAGR 5-Years
17%
CAGR 10-Years
27%
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Cash & Cash Equivalents
ÂĄ1.8B
CAGR 3-Years
14%
CAGR 5-Years
-2%
CAGR 10-Years
29%
No Stocks Found

Adicon Holdings Ltd
Glance View

Market Cap
4.5B HKD
Industry
Health Care

ADICON Holdings Ltd. engages in the provision of independent clinical laboratory services. The company is headquartered in Hangzhou, Zhejiang and currently employs 6,128 full-time employees. The company went IPO on 2023-06-30. The firm primarily provides testing services to hospitals, medical institutions, medical examination centers, consumers, pharmaceutical companies and contract research organizations (CROs). The firm's inspection services mainly include routine tests, esoteric tests, clinical immunologic testing, clinical chemistry testing, clinical molecular biology testing, pathology testing and others testing. The firm is also engaged in the sales of medical testing equipment. The firm principally conducts its businesses in the domestic market.

Intrinsic Value
9.48 HKD
Undervaluation 34%
Intrinsic Value
Price
A

See Also

What is Adicon Holdings Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.7B CNY

Based on the financial report for Dec 31, 2023, Adicon Holdings Ltd's Cash & Cash Equivalents amounts to 1.7B CNY.

What is Adicon Holdings Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
11%

Over the last year, the Cash & Cash Equivalents growth was -1%. The average annual Cash & Cash Equivalents growth rates for Adicon Holdings Ltd have been 11% over the past three years .

Back to Top